Abstract: Ledebouria revoluta, Berkheya setifera and Carissa bispinosa are some of the medicinal plants used in South African traditional medicine. An investigation to evaluate antimicrobial, anti-inflammatory and free radical scavenging activities of the root crude extracts and fractions from the three plants was carried out. Reduction by 2, 2-azinobis (3-ethylbenzothiazoline)-6-sulfonic acid (ABTS*) and 2, 2-di (4-tertoctylpheny1)-1-picrylhydrazyl (DPPH ) radicals were used to assess antioxidant capacities by change in absorbance in a UV-VIS spectrophotometer. Anti-inflammatory activity of the plant extracts against 15-soybean derived lipoxygenase (15-LOX) enzyme was evaluated as increase in absorbance at 234 nm after addition of soya bean derived 15-LOX, using linoleic acid (134 pM) as substrate. Anti-microbial activities were determined by assessing the plant samples' Minimum Inhibitory Concentrations (MICs) by a micro dilution method. Carissa bispinosa and Berkheya setifera have shown good to moderate antimicrobial activity. Ledebouria revoluta displayed good activities (20 pg/mL) for both acetone and methanol fractions against E. coli and good-moderate activity (160-320 pg/mL) against the rest of the bacterial strains used. Anti-fungal activity for Ledebouria revoluta methanol fraction (20 pg/mL) is high against Candida albicans. Percentage inhibition of 15-soybean lipoxygenase enzyme by the crude extracts at concentration of 25 pg/mL was for Berkheya setifera, 80%, Carissa bispinosa, 65% and Ledebouria revoluta, 40%.
INTRODUCTION
Identification and characterization of physiologically active constituents from plant extracts leads to the development of new drugs and the information produces a valuable database for creating new formulas. It has been estimated that 14-28% of higher plant species are used medicinally and that 74% of pharmacologically active plant derived components were discovered after following up on ethno-medicinal use of the plants (Ncube, 2008) . Traditionally used medicinal plants have recently attracted the attention of the pharmaceutical and scientific communities. This has involved the isolation and identification of secondary metabolites produced by plants and their use as active principles in medicinal preparations (Taylor and Van Staden, 2001 ). Many of the plant secondary metabolites are constitutive, existing in healthy plants in their biologically active forms, but others occur as inactive precursors and are activated in response to tissue damage or pathogen attack (Osbourne, 1996) . Natural Products contribute significantly as a source for derivation of lead compounds and development of drugs that are introduced into the market. Traditional knowledge applications and its use of plant extracts in medicinal practices provide an excellent database for potential identification of sources that may yield lead compounds with bioactive properties. New pathogens are fast emerging and with some of them being resistant to existent drugs hence the focus to research in medicinal plant extracts. Reserves of herbs and stocks of medicinal plants in developing countries are diminishing and in danger of extinction as a result of growing trade demands for cheaper health care products and new plant based therapeutic markets in preference to more expensive target specific drugs and biopharmaceuticals (Hoareau, 1999) . Although 3-benzyl-4-chromanones(homoisoflavanones) have been isolated from Ledebouria revoluta (Moodley et a/., 2006) , more research has to be done on further isolation and identification of the plant's secondary metabolites to validate its use in traditional medicine (Table 1) . Reports on the biological activities, isolation and identification of secondary metabolites in Berkheya setifera and Carissa bispinosa have not yet been made. All the three plants are claimed to be used in treating inflammation and other complications resulting from it. The aim of this study is to scientifically validate the traditional use of these plants in treating infections and (Watt and Breyer-Brandwijk, 1962; Dold and Cocks, 2001; Abegaz, 2002; Moodley, 2006 Plant treatment: Plant root and bulb materials were washed, air dried at room temperature for three weeks and ground to powder using a Lasec Polymix PX-MFC 90D crusher. Dried plant pulverized material was stored in glass containers in a cool dry place. Crude extracts were made by shaking plant powder (200 g) in a ratio of 1 g to 10 mL solvent for 6 h (Elloff, 1998) . Excess solvent was recovered on a rotary vapor until the extract was concentrated. The concentrated slurry was dried at room temperature in the fume hood. The crude plant extract was stored in the fridge at 4°C until it is required for biological assays.
Liquid-liquid extraction (Fractionation):
Dried crude extracts were dissolved in 70% acetone in a separating funnel and extracted with hexane, dichloromethane and ethyl acetate respectively (Fig. 1 ). The residual water fraction was dried in a conventional oven at 50°C for 96 h. Absolute methanol was added every 24 h to prevent the growth of fungi. The dried water fractions were extracted with acetone and methanol successively to produce fractions of different polarities. Fractions were concentrated on a rotary evaporator and then air dried at room temperature under a fan. The dried fractions were weighed and results are recorded in Table 2 . The fractionation protocol is presented in Fig. 1 . (Eloff, 1998) . In brief, 100 pL distilled water was placed in each of the wells using a multichannel micropipette. Thereafter, 100 pL of extract (10 mg/mL) was added to the first well of column and serially diluted to prepare a concentration range between 5.0 and 0.04 mg/mL in the first well and last well, respectively. The solvent blank (negative control) and antibiotic (gentamicin for bacteria and amphotericin B for fungi) were included as positive control. From an overnight culture of bacteria grown in diluted Mueller Hinton broth, 100 pL of relevant bacteria dispensed into each well and incubated at 37°C for 18-24 h before adding 40 pL (0.2 mg/mL) of INT (iodonitrotetrazolium violet, Sigma) solution. Color change was noted after 30, 60 and 120 min to obtain the lowest concentration where growth was inhibited (MIC). Minimum inhibitory concentrations (MIC) of the crude extracts and fractions against Candida albicans and Aspergillus fumigatus were determined using the above-mentioned serial dilution assay with some modifications and the fungal stock was prepared using Sabouraud dextrose broth instead of Mueller Hinton broth used for bacteria culture.
DPPH anti-oxidant assay: For DPPH anti-oxidant assay, using 96 well plates and a VERSAmaxTM tunable microplate reader (Labotech), 40 pL of 0,5 mg/mL plant extract and fraction was determined by a twofold serial dilution in 160 pL of 0.0025% of DPPH (total volume 200 pL), methanol (negative control) or trolox (positive control 516 nm wavelength. Methanol was used as negative control and trolox (25-0.5 g/mL) was used as positive control. The free radical DPPH" scavenging (reduction) was calculated from the equation:
where, A is absorbance of DPPH solution with methanol, A, is absorbance of a DPPH solution with a tested fraction solution or trolox (positive control).
ABTS' Scavenging assay:
The ABTS radical cation was prepared by mixing 7 mM ABTS stock solution and incubating for 12-16 h in the dark at room temperature until a steady absorbance was obtained to indicating that the reaction was complete. Plant extracts and fractions (40 pL of 0.5 mg/mL) were mixed with 160 pL of the ABTS' radical cation (total volume 200 pL) in a 96-well microtitre plate. Absorbance of the mixture was read at 734 after six minutes using VERSAmaxTM tunable microplate reader (Labotech). Methanol was used as negative control and trolox (25-0.5 g/mL) was used as positive control.
Lipoxygenase inhibition: Inhibitory activity of the plant extracts against 15-soybean lipoxygenase (15-LOX) enzyme was evaluated as described by Malterud and Rydland (2000) in borate buffer (0.2 M, pH 9.00).
Increase in absorbance at 234 nm was read 5 min at interval of 30 s after addition of 15-LOX, using linoleic acid (134 NM) as substrate. The final enzyme concentration was 167 pg/mL. Test substances were added as DMSO solutions (final DMSO concentration of 1.6%) while DMSO alone was added in control experiments. The enzyme solution was kept on ice and controls were measured at intervals throughout the experimental periods to ensure that the enzyme activity was constant. All measurements were carried out three times. 20<  320  625  160  320  160  320  160  625  320  20<  160  625  160  80  160  320  80  625  320  320  160  625  160  160  160  320  160  625  320  160  320  625  160  160  625  160  160  625  320  320  160  1250  320  320  320  320  320  20  320  320  160  1250  320  320  160  160  320  1250  1250  4 
RESULTS
Investigations for different biological assays revealed that crude extracts and fractions of differing polarities had varied activities depending on the assays carried out. Results from the DPPH and ABTS'. scavenging assay investigations with Ledebouria revoluta, Berkheya setifera and Carissa bispinosa root extracts and fractions are diplayed in Table 5 . Results for the 15-LOX anti-inflammatory assay displayed in Table 3 indicate that the crude extracts had some antiinflammatory activities. The minimum inhibitory concentrations of the methanol crude extracts and fractions were presented in Table 4 display high to moderate antimicrobial activities.
Yield: Berkheya setifera had the highest percentage yield of 10% aetone crude extract while lower yieds of 2.5% were obtained with Ledebouria revoluta and Carissa bispinosa.The highest non polar fraction was from Berkheya setifera hexane nfraction of 46%. The lowest yield was from Carissa bispinosa of 0.02%. Berkheya setifera had then highest amount of the methanol fraction of 6.2% (Table 2 ).
Antimicrobial activities: Most samples from the three plants had high to moderate antimicrobial activities (20-320 pg/mL) as displayed in Table 4 . However some low antifungal activities (1250 pg/mL) were exhibited by fewer samples of methanol fractions of Berkheya setifera against Candida albicans and Aspergillus fumigatus. The acetone fraction of Berkheya setifera had high activity against Candida albicans of 20 pg/mL.
Antioxidant and lipoxygenase inhibitory activity:
Plant samples displayed differing antioxidant and lipoxygenase inhibitory activity depending on the polarity of sample. In general, most activity was displayed by the polar acetone and methanol fractions. Berkheya setifera crude sample displayed the highest activity of EC" 2.471 pg/mL against DPPH and 1.967 pg/mL with ABTS radical ion comparing with very well with trolox (0.04 pg/mL). The other two plant crude extracts displayed moderate activates of compared to the activities of their fractions.
DISCUSSION
Ledebouria revoluta displayed good activities (20 pg/mL) for both acetone and methanol fractions against E. coli and good-moderate activity (160-320 pg/mL) against the rest of the bacterial strains used. Anti-fungal activity for Ledebouria revoluta methanol fraction (20 pg/mL) is high against Candida albicans. The bulb infusion of Ledebouria revoluta are used diarrhea in goats and leaf decoction for gall sickness (Dold and Cocks (2002) Carissa bispinosa acetone fraction displayed high activity ECso of 1.108 pg/mL against ABTS radical ion when compared to the rest of the fractions. Although the Carissa bispinosa acetone fraction corresponding activity against DPPH free radical ECso of 11.18 pg/mL, the activity is the highest when compared to other fractions and crude of the same plant and acetone fractions of the other two plants. Most antioxidants are extracted by methanol as displayed by the fractions of Berkheya setifera (EC50 1.008 pg/mL) and Ledebouria revoluta (ECso 1.867 pg/mL) against DPPH radical. This antioxidant activity is linked to the antimicrobial activity of the same acetone methanol fractions which whose activities were between 20 and 320 pg/mL excluding the activity against the fungal strains Candida albicans and Aspergillus fumigatus (EC50 1250 pg/mL) which were low. Soya bean derived 15 LOX inhibitory activity of crude extracts of Carissa bispinosa (EC50 12.24 pg/mL) and Berkheya setifera (EC50 11.91 pg/mL) were high and also have and radical and antimicrobial activities. These observations were significant because LOXs are the family of the key enzymes in the biosynthesis of leukotrienes that are postulated to play an important role in the pathophysiology of several inflammatory diseases (Rackova et al., 2007) . Plants have been reported before to be used to manage inflammation related conditions (Iwalewa et al., 2007) . Results obtained during this study illustrate that Ledebouria revoluta, Berkheya setifera and Carissa bispinosa root extracts and fractions can be used in the treatment of inflammation related diseases.
Conclusion:
A relationship between the 15 LOX inhibitory activity, antimicrobial and anti-radical activities illustrate that the crude fractions have medicinal value and explain why traditional healers use them to manage inflammation and related diseases. Although the in vitro investigations illustrate that the extracts and fractions of root samples of Ledebouria revoluta, Berkheya setifera and Carissa bispinosa have medicinal properties, there is need for more in vivo investigationstions for recommendations of such plants to be used in medicine in managing inflammation.
